Long-Term Rescue of Dystrophin Expression and Improvement in Muscle Pathology and Function in Dystrophic Mdx Mice by Peptide-Conjugated Morpholino Public Deposited

http://ir.library.oregonstate.edu/concern/defaults/wd375x04j

This is the author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Elsevier and can be found at:  http://www.journals.elsevierhealth.com/periodicals/ajpa/.

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • Exon skipping is capable of correcting frame-shift and nonsense mutations of Duchenne Muscular Dystrophy (DMD). Phase II clinical trials in UK and Netherlands have reported induction of dystrophin expression in muscles of DMD patients by systemic administrations of both phosphorodiamidate morpholino oligomers (PMO) and 2’O methyl phosphorothioate. Peptide-conjugated PMO (PPMO) offers significantly higher efficiency than PMO with the ability to induce near normal levels of dystrophin and restores functions in both skeletal and cardiac muscles. Here, we examined one year systemic efficacy of PPMO targeting exon 23 in dystrophic mdx mice. LD50 of the PPMO was approximately 85mg/kg. Half life of the dystrophin expression was about 2 months in skeletal muscles but shorter in cardiac muscle. Biweekly injection of 6 mg/kg PPMO produced higher than 20% dystrophin expression in all skeletal muscles, and up to 5% in cardiac muscles with improvement in muscle function and pathology, and reduction in the levels of serum creatine kinase (CK). Monthly injections of 30mg/kg PPMO restored dystrophin to more than 50% normal levels in all of skeletal muscles, but 15% in cardiac muscle. This was associated with greatly reduced serum CK levels, near normal histology, and functional improvement of skeletal muscles. Our result demonstrated for the first time that one year regular administration of PPMO could be safely applied to achieve significant therapeutic effect in animal models.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Wu, B., Lu, P., Cloer, C., Shaban, M., Grewal, S., Milazi, S., . . . Lu, Q. (2012). Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino. American Journal of Pathology, 181(2), 392-400. doi: 10.1016/j.ajpath.2012.04.006
Academic Affiliation
Series
Rights Statement
Funding Statement (additional comments about funding)
Publisher
Peer Reviewed
Language
Replaces
Additional Information
  • description.provenance : Submitted by Deanne Bruner (deanne.bruner@oregonstate.edu) on 2013-03-14T00:33:00Z No. of bitstreams: 1 MoultonHongVeterinaryMedicineLongTermRescue.pdf: 17187695 bytes, checksum: e82974a94d1e34c3e7b1db531da07416 (MD5)
  • description.provenance : Approved for entry into archive by Deanne Bruner(deanne.bruner@oregonstate.edu) on 2013-03-14T00:35:25Z (GMT) No. of bitstreams: 1 MoultonHongVeterinaryMedicineLongTermRescue.pdf: 17187695 bytes, checksum: e82974a94d1e34c3e7b1db531da07416 (MD5)
  • description.provenance : Made available in DSpace on 2013-03-14T00:35:25Z (GMT). No. of bitstreams: 1 MoultonHongVeterinaryMedicineLongTermRescue.pdf: 17187695 bytes, checksum: e82974a94d1e34c3e7b1db531da07416 (MD5) Previous issue date: 2012-08

Relationships

In Administrative Set:
Last modified: 07/13/2017

Downloadable Content

Download PDF
Citations:

EndNote | Zotero | Mendeley

Items